UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Wound complications following kidney and liver transplantation

Clinical transplantation, 2006-12, Vol.20 (s17), p.97-110

2006

Volltextzugriff (PDF)

Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience

Journal of viral hepatitis, 2006-04, Vol.13 (4), p.256-263

2006

Volltextzugriff (PDF)

Fulminant hepatic failure: etiology and indications for liver transplantation

Nephrology, dialysis, transplantation, 2007-09, Vol.22 (suppl-8), p.viii5-viii8

2007

Volltextzugriff (PDF)

Conversion of sound into auditory nerve action potentials

HNO, 2016-11, Vol.64 (11), p.808-814

2016

Volltextzugriff (PDF)

Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection

Clinical and experimental immunology, 2005-11, Vol.142 (2), p.362-369

2005

Volltextzugriff (PDF)

Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation

Nephrology, dialysis, transplantation, 2007-09, Vol.22 (suppl-8), p.viii54-viii60

2007

Volltextzugriff (PDF)

Activation of natural killer cells by hepatitis C virus particles in vitro

Clinical and experimental immunology, 2011-09, Vol.165 (3), p.352-362

2011

Volltextzugriff (PDF)

Extended Donor Criteria Have No Negative Impact on Early Outcome After Liver Transplantation: A Single-Center Multivariate Analysis

Transplantation proceedings, 2007-03, Vol.39 (2), p.529-534

2007

Volltextzugriff (PDF)

Biliary complications after liver transplantation

Clinical transplantation, 2006-12, Vol.20 (s17), p.93-96

2006

Volltextzugriff (PDF)

Immunosuppression and modulation in liver transplantation

Nephrology, dialysis, transplantation, 2004-07, Vol.19 (suppl-4), p.iv22-iv25

2004

Volltextzugriff (PDF)

The role and value of sirolimus administration in kidney and liver transplantation

Clinical transplantation, 2006-12, Vol.20 (s17), p.30-43

2006

Volltextzugriff (PDF)

1855P Logistic and documentary factors influencing reasonable tumorboard decisions

Annals of oncology, 2021-09, Vol.32, p.S1249-S1249

2021

Volltextzugriff (PDF)

Codierung von Schallsignalen in Aktionspotenziale des auditorischen Nervs

HNO, 2016-11, Vol.64 (11), p.808-814

2016

Volltextzugriff (PDF)

893 VARIATIONS OF VITAMIN D LEVELS IN GENOTYPE 1HEPATITIS C PATIENTS UNDERGOING ANTIVIRAL THERAPY CORRELATE WITH STAGE OF FIBROSIS BUT NOT WITH TREATMENT OUTCOME

Journal of hepatology, 2012-04, Vol.56, p.S347-S347

2012

Volltextzugriff (PDF)

Fatal varicella in an immunocompromised adult associated with a European genotype E2 variant of varicella zoster virus

Journal of clinical virology, 2009-01, Vol.44 (1), p.70-73

2009

Volltextzugriff (PDF)

An Early Increase in Gamma Glutamyltranspeptidase And Low Aspartate Aminotransferase Peak Values Are Associated With Superior Outcomes After Orthotopic Liver Transplantation

Transplantation proceedings, 2009-06, Vol.41 (5), p.1727-1730

2009

Volltextzugriff (PDF)

1350 HOST-SPECIFIC FACTORS INDEPENDENT OF IL28B GENOTYPE PREDICTING TREATMENT OUTCOME OF INDIVIDUALIZED THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 INFECTION

Journal of hepatology, 2011-03, Vol.54, p.S533-S533

2011

Volltextzugriff (PDF)

1349 VIROLOGIC RELAPSE IS HIGHLY CORRELATED WITH RESPONSE AT WEEK 4 AND 12 BUT NOT WITH IL28B GENOTYPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH PEG-INTERFERON/RIBAVIRIN

Journal of hepatology, 2011-03, Vol.54, p.S532-S533

2011

Volltextzugriff (PDF)

483 IMPORTANCE OF HCV RNA ASSAY CHARACTERISTICS AND DIFFERENCES BETWEEN ASSAYS FOR RESPONSE GUIDED THERAPY OF CHRONIC HEPATITIS C

Journal of hepatology, 2011-03, Vol.54, p.S198-S198

2011

Volltextzugriff (PDF)

Development of a heterologous, multigenotype vaccine against hepatitis C virus infection

European journal of clinical investigation, 2007-05, Vol.37 (5), p.396-406

2007

Volltextzugriff (PDF)

587 BONE-MARROW DERIVED DENDRITIC CELLS CAN EFFECTIVELY BE PULSED BY HBVSVP AND INDUCE SPECIFIC IMMUNE RESPONSES IN BALB/C MICE

Journal of hepatology, 2009, Vol.50, p.S216-S216

2009

Volltextzugriff (PDF)

54 COMPLETELY INDIVIDUALIZED TREATMENT DURATIONS (24, 30, 36, 42, 48, 60 OR 72 WEEKS) WITH PEGINTERFERON-ALFA-2B AND RIBAVIRIN IN HCV GENOTYPE 1-INFECTED PATIENTS (INDIV-2 STUDY)

Journal of hepatology, 2010, Vol.52, p.S25-S26

2010

Volltextzugriff (PDF)

HCV core beeinflusst die Antigenpräsentation in Leberzellen und führt zu verminderter NK-Zellaktivität

Zeitschrift für Gastroenterologie, 2015, Vol.41 (8)

2015

Volltextzugriff (PDF)

Der Sternenhimmel

F. Kaiser / Franz Schlegel

2021

Volltextzugriff (PDF)

CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization

Archives of virology, 2003-03, Vol.148 (3), p.435-448

2003

Volltextzugriff (PDF)

1 – 25 von 271

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(218)
Mit Volltextzugriff
(175)

Publikationsform

Sprache

Englisch
(167)
Deutsch
(113)

Erscheinungsjahr

n.n

Thema

Humans
(101)
Science & Technology
(85)
Life Sciences & Biomedicine
(84)
Biological And Medical Sciences
(52)
Medical Sciences
(42)
Male
(40)
Female
(38)
Animals
(35)
Adult
(34)
Surgery
(31)
Transplantation
(28)
Middle Aged
(27)
Fundamental And Applied Biological Sciences. Psychology
(21)
Immunology
(21)
Cells, Cultured
(18)
Liver Transplantation
(18)
Mice
(15)
Treatment Outcome
(15)
Aged
(14)
Hepatitis C Virus
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Wound complications following kidney and liver transplantation

Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience

Fulminant hepatic failure: etiology and indications for liver transplantation

Conversion of sound into auditory nerve action potentials

Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection

Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation

Activation of natural killer cells by hepatitis C virus particles in vitro

Extended Donor Criteria Have No Negative Impact on Early Outcome After Liver Transplantation: A Single-Center Multivariate Analysis

Biliary complications after liver transplantation

Immunosuppression and modulation in liver transplantation

The role and value of sirolimus administration in kidney and liver transplantation

1855P Logistic and documentary factors influencing reasonable tumorboard decisions

Codierung von Schallsignalen in Aktionspotenziale des auditorischen Nervs

893 VARIATIONS OF VITAMIN D LEVELS IN GENOTYPE 1HEPATITIS C PATIENTS UNDERGOING ANTIVIRAL THERAPY CORRELATE WITH STAGE OF FIBROSIS BUT NOT WITH TREATMENT OUTCOME

Fatal varicella in an immunocompromised adult associated with a European genotype E2 variant of varicella zoster virus

An Early Increase in Gamma Glutamyltranspeptidase And Low Aspartate Aminotransferase Peak Values Are Associated With Superior Outcomes After Orthotopic Liver Transplantation

1350 HOST-SPECIFIC FACTORS INDEPENDENT OF IL28B GENOTYPE PREDICTING TREATMENT OUTCOME OF INDIVIDUALIZED THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 INFECTION

1349 VIROLOGIC RELAPSE IS HIGHLY CORRELATED WITH RESPONSE AT WEEK 4 AND 12 BUT NOT WITH IL28B GENOTYPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH PEG-INTERFERON/RIBAVIRIN

483 IMPORTANCE OF HCV RNA ASSAY CHARACTERISTICS AND DIFFERENCES BETWEEN ASSAYS FOR RESPONSE GUIDED THERAPY OF CHRONIC HEPATITIS C

Development of a heterologous, multigenotype vaccine against hepatitis C virus infection

587 BONE-MARROW DERIVED DENDRITIC CELLS CAN EFFECTIVELY BE PULSED BY HBVSVP AND INDUCE SPECIFIC IMMUNE RESPONSES IN BALB/C MICE

54 COMPLETELY INDIVIDUALIZED TREATMENT DURATIONS (24, 30, 36, 42, 48, 60 OR 72 WEEKS) WITH PEGINTERFERON-ALFA-2B AND RIBAVIRIN IN HCV GENOTYPE 1-INFECTED PATIENTS (INDIV-2 STUDY)

HCV core beeinflusst die Antigenpräsentation in Leberzellen und führt zu verminderter NK-Zellaktivität

Der Sternenhimmel

CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization

Suchergebnisse filtern